PMID: 15373220Sep 18, 2004Paper

Liver-targeted regenerative medicine

Nihon Geka Gakkai zasshi
Naoya KobayashiNoriaki Tanaka

Abstract

Recently, much attention has been drawn to liver-targeted regenerative medicine for the treatment of liver failure. Researchers in various fields consider that the following cells can be used for such therapy: human embryonic stem (ES) cells, somatic stem cells, hepatic stem cells, small hepatocytes, bone marrow- and cord blood-derived hepatic progenitor cells, and human hepatocyte cell lines. The Cre/loxP-based reversible immortalization of human hepatocytes is also introduced in this review article. Here we describe the candidates that can contribute to hepatic regeneration. This reversible immortalization system allows us to establish a highly safe human hepatocyte line that is capable of differentiation at a lower cost and on a larger scale.

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Journal of Artificial Organs : the Official Journal of the Japanese Society for Artificial Organs
Naoya KobayashiNoriaki Tanaka
The Keio Journal of Medicine
Naoya KobayashiNoriaki Tanaka
Biochemical and Biophysical Research Communications
Min Jeong SeoJin Sup Jung
© 2021 Meta ULC. All rights reserved